Member Info for jollygoodya

Sorry chaps was away from desk. Looks like we're on the prowl with our additional funds... pretty good update on the second RNS. Directors partaking in the placing too.
All to play for, looking forward with this. I've added more at not far off placing price. This is now bottom rung entry point imo.

Has certainly de-risked these price levels. Oversubscription indicates investors see this as a decent buy in price for gains. Big move coming here. Things are really hotting up imo.

Explains recent price action. But done at a good price. Looks like more news on the way at some point soon. So should rise now, with finance sorted.

Ygen driving forward as a business. Out testing with the accuracy levels of 99% is superb. Matter of time. Will top up big if I get a chance. This is a rare investment case on aim!!

Expects to be able to produce 200,000 per week in October and able to increase capacity if needed... timing for 'next wave'. Abc19 rapid test production at SCALE by August end. My opinion are orders are inbound and we're ready to go. You don't set production scales otherwise...

Turning green. Expecting a push up.

Excellent progress, orders now expected. Hit by wave of sellers atm. Expecting a rise to 70 plus after it sells. Matter of time for the orders news

Interesting to note, order book, starting to go green. A few impatient peeps sold. Looking for top up funds soon.

Given up guessing on lse. Tend to think sell, given sp action.

Agree richmanpoorman. Reason for mooted sp reaction this morning. Ticking back up nicely now.

draft, key point on cash is the reduction of cash burn over 50% burn reduction. No one saying it's the polished article yet. However it is a company on the rise and with sales and revenue growth at the pace it is. Cash position will strengthen, faster than you think. We have a varied portfolio of products too. If you cant see an investment case don't invest?

Excellent presentation. Very polished. A lot of positives. US market continued penetration will be a big future driver. Developing into a global business. New acquistions bedding in nicely too. Good to see positive contributions.

Agree with a lot of posts here, newsflow rich period..Today sets out the foundations of the company. Sp driver news to come.

CooperD, a real investors share this will be. Classico with patience required. BoD strategy looks strong and I'm staying in long here.

Medium to longer term hold. The way it's set up and the rns release which confirms the earlier update indicates not a boom or bust stock but a value play in the making. I'm ok with sp reaction and my strategy to continue to add.

"The reorientation of the business to focus on our key four strategic growth drivers is starting to bear fruit, and I remain convinced we have a very significant opportunity ahead of us. We are confident in our outlook for the year ahead, even before potential COVID-related product and service revenues, and we are very excited about the prospects for further growth in the coming years."

Just added more. Turnaround story in play with significant growth prospects.

Natdan, appears to be so. Will continue to build holding here. All things being equal, has the potential to be a far larger company. Really like the prospects here.

Bought in yesterday. Will be adding on dips. Expecting a substantial rise at some point. The target market is huge. Scope to detect new variants with tweeks. Big news on horizon imo.

https://www.fiercebiotech.com/biotech/synairgen-shares-soar-300-covid-treatment-but-caveats-abound

https://www.cnbc.com/2020/07/20/synairgen-says-small-coronavirus-treatment-trial-could-signal-major-breakthrough.html